(19)
(11) EP 2 076 247 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
24.05.2017 Bulletin 2017/21

(45) Mention of the grant of the patent:
23.11.2016 Bulletin 2016/47

(21) Application number: 07867189.8

(22) Date of filing: 02.10.2007
(51) International Patent Classification (IPC): 
A61K 9/14(2006.01)
A61P 23/02(2006.01)
 A61K 9/16(2006.01)
(86) International application number:
PCT/US2007/021139
(87) International publication number:
WO 2008/060365 (22.05.2008 Gazette 2008/21)

(54)

A SELF-GELLING TUNABLE DRUG DELIVERY SYSTEM

SELBST-GELIERENDES EINSTELLBARES ARZNEIABGABESYSTEM

SYSTÈME D'ADMINISTRATION DE MÉDICAMENT ACCORDABLE AUTOGÉLIFIANT

(84) Designated Contracting States:
DE FR GB IT

(30) Priority: 27.10.2006 US 588612

(43) Date of publication of application:
08.07.2009 Bulletin 2009/28

(73) Proprietor: ETHICON, INC.
Somerville, NJ 08876 (US)

(72) Inventors:
  • SCHACHTER, Deborah M.
    Edison, NJ 08817 (US)
  • ZHOU, Yue
    Horseheads, NY 14845 (US)

(74) Representative: Kirsch, Susan Edith et al
Carpmaels & Ransford LLP One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
EP-A1- 1 595 534
US-A1- 2003 203 030
 WO-A1-2006/053836
US-A1- 2006 188 583
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).